Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provi...
Leadership
Mitchell S. Steiner F.A.C.S., M.D.
Chairman, President & CEO
Harry D. Fisch F.A.C.S., M.D.
Vice Chairman & Chief Corporate Officer
K. Gary Barnette Ph.D.
Chief Scientific Officer
Michele Greco CPA
CFO & Chief Administrative Officer
Samuel Fisch
Executive Director of Investor Relations & Corporate Communications
Philip R. Greenberg J.D.
Executive VP, General Counsel & Secretary
Kevin J. Gilbert CPA, J.D.
Executive Vice President of Corporate Development
Martin Tayler
Executive Vice President of FC2 Global Operations
Domingo Rodriguez M.D.
Executive Vice President of Global Clinical Operations
Gary Bird Ph.D.
Executive Vice President of Quality & Regulatory Affairs
